The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Central Nervous System (CNS) Therapeutic Market Research Report 2024

Global Central Nervous System (CNS) Therapeutic Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1894692

No of Pages : 80

Ask Your Query

Synopsis

A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.

The global Central Nervous System (CNS) Therapeutic market was valued at US$ 74150 million in 2023 and is anticipated to reach US$ 93600 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Therapeutic.

Report Scope

The Central Nervous System (CNS) Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Central Nervous System (CNS) Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Central Nervous System (CNS) Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Pfizer
  • Biogen
  • Johnson & Johnson
  • Eli Lilly
  • Otsuka America Pharmaceutical
  • Merck
  • Astrazeneca
  • Novartis
  • Teva Pharmaceutical Industries
  • Takeda

Segment by Type

  • Neurovascular
  • Trauma
  • Mental Health
  • Degenerative Disorder
  • Infections
  • Cancer

Segment by Application

  • Clinical Application
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Neurovascular
1.2.3 Trauma
1.2.4 Mental Health
1.2.5 Degenerative Disorder
1.2.6 Infections
1.2.7 Cancer
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Application
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2019-2030)
2.2 Central Nervous System (CNS) Therapeutic Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Central Nervous System (CNS) Therapeutic Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutic Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2023
3.5 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2025-2030)
5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2019-2030)
6.2 North America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2019-2030)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2019-2030)
9.2 Latin America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Detail
11.5.2 Otsuka America Pharmaceutical Business Overview
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.5.5 Otsuka America Pharmaceutical Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Company Detail
11.7.2 Astrazeneca Business Overview
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.7.5 Astrazeneca Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Detail
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)
11.10.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock